Insider buying
~$4.95M1.5M sh @ $3.30
Traded Aug 1, 2025 · filed 4 days later
A major shareholder of Prime Medicine paid $4.95M out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PRME · NASDAQ · Biological Products, (No Diagnostic Substances)
Prime Medicine (PRME) · oqro.io/stocks/PRME · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.55−0.29 (−7.55%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Insider buying
Traded Aug 1, 2025 · filed 4 days later
A major shareholder of Prime Medicine paid $4.95M out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded Aug 1, 2025 · filed the same day
A major shareholder of Prime Medicine paid $10M out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month. Shares held went up 95% with this purchase.
Insider buying
Traded Aug 1, 2025 · filed the same day
A major shareholder of Prime Medicine paid $10M out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month. Shares held went up 95% with this purchase.
Insider buying
Traded Aug 1, 2025 · filed the same day
A Prime Medicine director paid $10M out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month. Shares held went up 95% with this purchase.
Insider buying
Traded Jun 30, 2025 · filed 1 day later
A major shareholder of Prime Medicine paid $53K out of pocket for Prime Medicine shares.
Insider buying
Traded Jun 23, 2025 · filed the same day
A major shareholder of Prime Medicine paid $45K out of pocket for Prime Medicine shares.
Insider buying
Traded Jun 16, 2025 · filed the same day
A major shareholder of Prime Medicine paid $31K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded Jun 11, 2025 · filed 1 day later
A major shareholder of Prime Medicine paid $34K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded May 21, 2025 · filed 1 day later
The CEO of Prime Medicine paid $147K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded May 21, 2025 · filed 1 day later
Prime Medicine's Chief Technical Officer paid $113K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded May 20, 2025 · filed 2 days later
Prime Medicine's Chief Business Officer paid $24K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
0 open-market purchases and 0 open-market sales by insiders of PRME between Feb 1, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 10, 2026. The data provider lists the next release for Mar 1, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 10, 2026 | None | None | None |
| Aug 6, 2026 | None | None | None |
| May 7, 2026 | None | None | None |
| Mar 3, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies